Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review

Role of Digital Health and Artificial Intelligence in Inflammatory Bowel Disease: A Scoping Review

Our review article was recently published in the peer reviewed journal, Genes!

In this article we discuss the current state of using digital health and artificial intelligence in the diagnosis, treatment, and monitoring of inflammatory bowel disease. Take a look at our abstract below for a summary and click this link to read the full article!



Inflammatory bowel diseases (IBD), subdivided into Crohn’s disease (CD) and ulcerative colitis (UC), are chronic diseases that are characterized by relapsing and remitting periods of inflammation in the gastrointestinal tract. In recent years, the amount of research surrounding digital health (DH) and artificial intelligence (AI) has increased. The purpose of this scoping review is to explore this growing field of research to summarize the role of DH and AI in the diagnosis, treatment, monitoring and prognosis of IBD. A review of 21 articles revealed the impact of both AI algorithms and DH technologies; AI algorithms can improve diagnostic accuracy, assess disease activity, and predict treatment response based on data modalities such as endoscopic imaging and genetic data. In terms of DH, patients utilizing DH platforms experienced improvements in quality of life, disease literacy, treatment adherence, and medication management. In addition, DH methods can reduce the need for in-person appointments, decreasing the use of healthcare resources without compromising the standard of care. These articles demonstrate preliminary evidence of the potential of DH and AI for improving the management of IBD. However, the majority of these studies were performed in a regulated clinical environment. Therefore, further validation of these results in a real-world environment is required to assess the efficacy of these methods in the general IBD population.
Download Injoy today!
Back to blog

Questions?Visit our FAQ or Chat with us at